Litton Mark James
PRESIDENT and CEO at LONA; Chief Business Officer at ALDER BIOPHARMACEUTICALS INC
- Sold, on record
- $5.6M
- Dollars the filings state
- Form 4 sales
- 22
- Latest Mar 4, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- LONAAthira Pharma, Inc.PRESIDENT and CEO
- ALDER BIOPHARMACEUTICALS INCChief Business Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- ALDER BIOPHARMACEUTICALS INC213,780 shares
- LONA75,784 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale LONANo planJan 5, 2024 2024
Sold 4,820 shares at $2.91 ($14k)
Litton Mark James, Chief Executive Officer
No 10b5-1 planSold 3.2% of holdings ($434k position)144,397 shares leftFiling
- 2 Form 4 sale LONANo planSep 5, 2024 +244 days
Sold 5,032 shares at $0.57 ($3k)
Litton Mark James, President and CEO
No 10b5-1 planSold 3.1% of holdings ($94k position)159,365 shares leftFollows a Form 144Filing
- 3 Form 144 notice LONANoticeSep 5, 2024 same day
Filed to sell 5,032 shares ($1)
Litton Mark James, Officer, Director
No 10b5-1 planFiling
- 4 Form 144 notice LONANoticeJan 2, 2025 +119 days
Filed to sell 25,107 shares ($14k)
Litton Mark James, Officer, Director
No 10b5-1 planFiling
- 5 Form 4 sale LONANo planJan 2, 2025 same day
Sold 25,107 shares at $0.56 ($14k)
Litton Mark James, President and CEO
No 10b5-1 planSold 9.4% of holdings ($150k position)242,591 shares leftFollows a Form 144Filing
- 6 Form 4 sale LONAUnusualJul 1, 2025 +180 days
Sold 25,123 shares at $0.29 ($7k)
Litton Mark James, President and CEO
No 10b5-1 planSold 7.2% of holdings ($102k position)325,802 shares left5x usual sizeFiling
- 7 Form 4 sale LONANo planJan 2, 2026 +185 days
Sold 2,586 shares at $6.88 ($18k)
Litton Mark James, President and CEO
No 10b5-1 planSold 6% of holdings ($299k position)40,828 shares left0.2x usual sizeFiling
- 8 Form 4 sale LONANo planMar 4, 2026 +61 days
Sold 5,156 shares at $5.37 ($28k)
Litton Mark James, PRESIDENT and CEO
No 10b5-1 planSold 8.2% of holdings ($339k position)57,926 shares left0.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (24)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 5, 2026 | LONA | PRESIDENT and CEO | Form 4 sale | 5,156 | $28k | 8.2% | No plan | SEC |
| Jan 2, 2026 | Jan 5, 2026 | LONA | President and CEO | Form 4 sale | 2,586 | $18k | 6.0% | No plan | SEC |
| Jul 1, 2025 | Jul 2, 2025 | LONA | President and CEO | Form 4 sale | 25,123 | $7k | 7.2% | Unusual | SEC |
| Jan 2, 2025 | Jan 3, 2025 | LONA | President and CEO | Form 4 sale | 25,107 | $14k | 9.4% | No plan | SEC |
| Jan 2, 2025 | Jan 2, 2025 | LONA | Officer, Director | Form 144 notice | 25,107 | $14k | Notice | SEC | |
| Sep 5, 2024 | Sep 5, 2024 | LONA | Officer, Director | Form 144 notice | 5,032 | $1 | Notice | SEC | |
| Sep 5, 2024 | Sep 5, 2024 | LONA | President and CEO | Form 4 sale | 5,032 | $3k | 3.1% | No plan | SEC |
| Jan 5, 2024 | Jan 8, 2024 | LONA | Chief Executive Officer | Form 4 sale | 4,820 | $14k | 3.2% | No plan | SEC |
| Jun 23, 2022 | Jun 24, 2022 | LONA | Chief Executive Officer | Form 4 sale | 7,960 | $21k | 5.8% | Plan not stated | SEC |
| Jun 1, 2018 | Jun 5, 2018 | ALDER BIOPHARMACEUTICALS INC | Chief Business Officer | Form 4 sale | 22,727 | $405k | 18.2% | Plan not stated | SEC |
| Nov 13, 2017 | Nov 15, 2017 | ALDER BIOPHARMACEUTICALS INC | Chief Business Officer | Form 4 sale | 16,519 | $178k | 14.2% | Plan not stated | SEC |
| Oct 16, 2017 | Oct 18, 2017 | ALDER BIOPHARMACEUTICALS INC | Chief Business Officer | Form 4 sale | 16,520 | $204k | 14.2% | Plan not stated | SEC |
| Jan 18, 2017 | Jan 20, 2017 | ALDER BIOPHARMACEUTICALS INC | Chief Business Officer | Form 4 sale | 1,498 | $35k | 1.5% | Plan not stated | SEC |
| Jan 9, 2017 | Jan 9, 2017 | ALDER BIOPHARMACEUTICALS INC | Chief Business Officer | Form 4 sale | 9,516 | $219k | 8.7% | Plan not stated | SEC |
| Oct 17, 2016 | Oct 19, 2016 | ALDER BIOPHARMACEUTICALS INC | Chief Business Officer | Form 4 sale | 6,000 | $165k | 18.8% | Plan not stated | SEC |
| Jun 13, 2016 | Jun 15, 2016 | ALDER BIOPHARMACEUTICALS INC | Chief Business Officer | Form 4 sale | 6,000 | $174k | 17.6% | Plan not stated | SEC |
| May 31, 2016 | Jun 1, 2016 | ALDER BIOPHARMACEUTICALS INC | Chief Business Officer | Form 4 sale | 25,000 | $751k | 25.1% | Unusual | SEC |
| Jan 4, 2016 | Jan 6, 2016 | ALDER BIOPHARMACEUTICALS INC | Chief Business Officer | Form 4 sale | 25,000 | $785k | 25.3% | Unusual | SEC |
| Oct 1, 2015 | Oct 5, 2015 | ALDER BIOPHARMACEUTICALS INC | Chief Business Officer | Form 4 sale | 7,500 | $242k | 9.3% | Plan not stated | SEC |
| Jul 1, 2015 | Jul 6, 2015 | ALDER BIOPHARMACEUTICALS INC | Chief Business Officer | Form 4 sale | 7,500 | $383k | 10.0% | Plan not stated | SEC |
| Jun 4, 2015 | Jun 8, 2015 | ALDER BIOPHARMACEUTICALS INC | Chief Business Officer | Form 4 sale | 25,000 | $1.1M | 25.0% | Unusual | SEC |
| Apr 1, 2015 | Apr 3, 2015 | ALDER BIOPHARMACEUTICALS INC | Chief Business Officer | Form 4 sale | 7,500 | $206k | 9.2% | Plan not stated | SEC |
| Jan 27, 2015 | Jan 28, 2015 | ALDER BIOPHARMACEUTICALS INC | Chief Business Officer | Form 4 sale | 7,500 | $211k | 8.4% | Plan not stated | SEC |
| Nov 20, 2014 | Nov 24, 2014 | ALDER BIOPHARMACEUTICALS INC | Chief Business Officer | Form 4 sale | 30,000 | $469k | 25.3% | Unusual | SEC |